Article

What’s the Cut-Point?: A Systematic Investigation of Tau PET Thresholding Methods

2021-10-14

Abstract excerpt

<title>Abstract</title> <p>Background: Tau positron emission tomography (PET) is increasing in popularity for biomarker characterization of Alzheimer’s disease (AD), and recent frameworks rely on tau PET cut-points to stage individuals along the AD continuum. Given the lack of standardization in tau PET thresholding methods, this study sought to systematically canvass and characterize existing studies that have d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 36115ba1-6a33-5a6d-96a8-3007afc65cce
DOI: 10.21203/rs.3.rs-962722/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

What’s the Cut-Point?: A Systematic Investigation of Tau PET Thresholding MethodsDOI 10.21203/rs.3.rs-962722/v1Read

CenTauR: Towards a Universal Scale and Masks for Standardizing Tau Imaging StudiesSemantic proximity Read

Exploring the intricacies and pitfalls of the ATN framework: An assessment across cohorts and thresholding methodologiesSemantic proximity Read

Optimal Combinations of Biomarkers to Determine AT(N) in the Alzheimer’s Disease Semantic proximity Read

Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s diseaseSemantic proximity Read

Identification of a simple and novel cut-point based CSF and MRI signature for predicting Alzheimer’s disease progression that reinforces the 2018 NIA-AA research frameworkSemantic proximity Read

A unified model for staging amyloid and tau pathology in Alzheimer’s diseaseSemantic proximity Read

Diagnosing Alzheimer’s Disease and Discriminating Between Its Stages from Brain FDG PET Images Using a New Platform for Radiomic AnalysisSemantic proximity Read

Detection of tau-PET positivity in clinically diagnosed mild cognitive impairment with multidimensional features.Semantic proximity Read

Provisional research criteria for the behavioral variant of Alzheimer’s disease A systematic review and meta-analysisSemantic proximity Read

Development and Clinical Validation of Global Tau Severity Score in Young- and Late- Onset Alzheimer's Disease Using Florzolotau (18F) PETSemantic proximity Read

Promising clinical tools for specific Alzheimer disease diagnosis from plasma pTau217 and ApoE genotype in a cognitive disorder unitSemantic proximity Read

Comprehensive evaluation of AT(N) imaging biomarkers for predicting cognitionSemantic proximity Read